Proactive and Progressive Approaches in Managing Obesity

References

• American Society of Bariatric Physicians. Obesity Algorithm^®. [cited 2016 Jan 23]. Available from: media.clinicaladvisor.com/documents/55/obesityalgorithm_13552.pdf
   Google Scholar
• Centers for Disease Control and Prevention. Obesity is common, serious, and costly. [cited 2016 Jan 22]. Available from: http://www.cdc.gov/obesity/data/adult.html
   Google Scholar
• Bays H, Scinta W. Adiposopathy and epigenetics: an introduction to obesity as a transgenerational disease. CurrMed Res Opin. Forthcoming.
   Web of Science ®Google Scholar
• Cassidy SB, Schwartz S, Miller JL, et al. Prader-Willi syndrome. Genet Med. 2012;14:10–26.
   PubMed Web of Science ®Google Scholar
• Bell AW, Ehrhardt RA. Regulation of placental nutrient transport and implications for fetal growth. Nutr Res Rev. 2002;15:211–230.
   PubMed Web of Science ®Google Scholar
• Barker DJP, Clark PM. Fetal Undernutrition and disease in later life. Rev Reprod. 1997;2:105–112.
   PubMedGoogle Scholar
• Hivert MB, Bouchard L, Franks PW. Maternal nutrition and epigenetics in early life. Curr Nutrition Rep. 2015;2:216–224.
   Google Scholar
• Soubry A, Murphy SK, Wang F, et al. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int J Obes (Lond). 2015;39:650–657.
   PubMed Web of Science ®Google Scholar
• Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25Suppl 2):S102–138.
   PubMed Web of Science ®Google Scholar
• Coll AP, Farooqi IS, O’Rahilly S. The hormonal control of food intake. Cell. 2007;129:251–262.
   PubMed Web of Science ®Google Scholar
• Field BC, Chaudhri OB, Bloom SR. Bowels control brain: gut hormones and obesity. Nat. Rev. Endocrinol. 2010;6:444–453.
   PubMed Web of Science ®Google Scholar
• Balthasar N, Dalgaard LT, Lee CE, et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell. 2005;123:493–505.
   PubMed Web of Science ®Google Scholar
• Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol. 2009;53:120–128.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Troiano RP. Changes in the distribution of body mass index of adults and children in the US population. Int J Obes Relat Metab Disord. 2000;24:807–818.
   PubMed Web of Science ®Google Scholar
• Yu YH, Vasselli JR, Zhang Y, et al. Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications. Obes Rev. 2015;16:234–247.
   PubMed Web of Science ®Google Scholar
• Yu JH, Kim MS. Molecular mechanisms of appetite regulation. Diabetes Metab J. 2012;36:391–398.
   PubMedGoogle Scholar
• Volkow ND, Wang GJ, Tomasi D, et al. Obesity and addiction: neurobiological overlaps. Obes Rev. 2013;14:2–18.
   PubMed Web of Science ®Google Scholar
• Tomasi D, Volkow ND. Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit Rev Biochem Mol Biol. 2013;48:1–19.
   PubMed Web of Science ®Google Scholar
• Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365:1597–1604.
   PubMed Web of Science ®Google Scholar
• Vandenbroeck P, Goossens J, Clemens M Tackling obesities: future choices – building the obesity system map. [cited2016 Jan 25]. Available at: www.foresight.gov.uk
   Google Scholar
• Baillot A, Romain AJ, Bolsvert-Vigneault K, et al. Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis. PLos One. 2015;10:e0119017.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care. 2016;39(Suppl. 1):S52–9.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–149.
   PubMed Web of Science ®Google Scholar
• Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2016 executive summary. Endocr Pract. 2016;22:84–113.
   PubMed Web of Science ®Google Scholar
• Munro JF, MacCuish AC, Wilson EM, et al. Comparison of continuous and intermittent anorectic therapy in obesity. Br Med J. 1968;1:352–354.
   PubMed Web of Science ®Google Scholar
• Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:1341–1352.
   PubMed Web of Science ®Google Scholar
• Wadden TA, Foreyt JP, Foster GD, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011;19:110–120.
   PubMed Web of Science ®Google Scholar
• Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363:245–256.
   PubMed Web of Science ®Google Scholar
• Wadden TA, Hollander P, Klein S, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Int J Obes. 2013;37:1443–1451.
   PubMed Web of Science ®Google Scholar
• Pi-Sunyer X, Astrup A, Fujioka K, et al. SCALE obesity and prediabetes NN8022-1839 study group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11–22.
   PubMed Web of Science ®Google Scholar
• Wharton S, Serodio KJ. Next generation of weight management medications: implications for diabetes and CVD risk. Curr Cardiol Rep. 2015;17:35.
   PubMed Web of Science ®Google Scholar
• Smith SR, Weissman NJ, Anderson CM, et al. Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363:245–256.
   PubMed Web of Science ®Google Scholar
• Apovian CM, Aronne L, Rubino D, et al. COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013;21:935–943.
   PubMed Web of Science ®Google Scholar
• Robert SA, Rohana AG, Shah SA, et al. Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide – A pilot study. Obes Res Clin Pract. 2015;9:301–304.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Kahn SE, Ferrannini E, et al. Endocrine Society; American Diabetes Association; European Association for the Study of Diabetes. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care. 2011;34:1424–1430.
   PubMed Web of Science ®Google Scholar
• Svetkey LP, Stevens VJ, Brantley PJ, et al. Weight Loss Maintenance Collaborative Research Group. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA. 2008;299:1139–1148.
   PubMed Web of Science ®Google Scholar
• Eckel RH. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med. 2008;358:1941–1950.
   PubMed Web of Science ®Google Scholar
• Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am. J. Physiol Endocrinol Metab. 2009;297:E271–88.
   PubMed Web of Science ®Google Scholar
• Klem ML, Wing RR, McGuire MT, et al. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1997;66:239–246.
   PubMed Web of Science ®Google Scholar
• McGuire MT, Wing RR, Klem ML, et al. Behavioral strategies of individuals who have maintained long-term weight losses. Obes Res. 1999;7:334–341.
   PubMedGoogle Scholar
• Johansson K, Neovius M, Hemmingsson E. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;99:14–23.
   PubMed Web of Science ®Google Scholar